Registration will open soon
Dear Friends and Colleagues,
IPOPI is delighted to invite you all to participate in the next International Primary Immunodeficiencies Congress – IPIC 5th Edition – which will be held in Vilamoura (Algarve), Portugal, in April 27-29, 2022.
IPIC was initially planned to take place in Germany in November 2021 but in light of on-going developments with COVID-19 and additional unexpected logistical circumstances, IPIC was moved to 2022 and to Portugal!
Our decision to move from Berlin to Vilamoura and push forward our dates by a few months is rooted in our determination to offer an optimized solution for our delegates and community. Prepare yourself for a congress experience and a scientific programme that will be well worth the wait!
The Algarve Congress Center in Vilamoura is our new venue, a great facility located in Southern Portugal and a mere 15min away from Faro international airport, with other nearby airports in Lisbon and Sevilla (Spain).
IPIC 5th Edition will bring together clinicians with an interest in primary immunodeficiencies (PIDs)/human inborn errors of immunity alongside leading physicians in the field, patient organisation representatives, nurses and other interested stakeholders. The Congress will build on our previous events and promises to deliver a diverse and stimulating scientific programme on the state of the art of diagnosis and clinical care of PIDs.
IPOPI is delighted to invite you to the next International Primary Immunodeficiencies Congress -IPIC 5th edition- which will be held on 27-29 April 2022 in Vilamoura (Algarve), Portugal!
IPOPI has once again teamed up with top scientific and clinical experts in the PID field to ensure the latest and most pressing clinical care priorities are featured on the programme.
IPOPI is glad to announced that preparations for the congress have already started and we have a great programme lined-up.
IPIC’s programme is prepared with the input of physicians, nurses and patients.
Very pleased to be a very small part of this important systematic review of treatment for #GLILD in #PID. May be of interest to those in @ipopi_info @ESIDsociety @theukpin and @EuroRespSoc. Completed in association with the ERS @glildnet CRC.
https://www.frontiersin.org/article/10.3389/fimmu.2021.606099
Subscribe to our mailling list to stay tuned